Industry NewsLab Automation Labcyte Commends Institute for Molecular Medicine Finland – Pfizer Leukemia Study Results
Editorial ArticleLife Sciences Immunotherapy Breakthrough for Autoimmune Diseases: An Exclusive Interview with Professor David Wraith
Industry NewsDrug discovery > Pre-Clinical Development Phase I Human Trials for Ebola Vaccine Begin this Week
Industry NewsGeneral Lab FluidX Awarded the Tender to Supply 2D Barcoded Sample Storage Tubes for the NAKO Cohort Study and Biobank
Product NewsClinical Diagnostics Ventana Paves the Way for Companion Diagnostic Early Phase Clinical Trials in China
Industry NewsSeparations SelectScience Opens Voting in the Scientists’ Choice Awards for Drug Discovery & Development Product of the Year
Industry NewsGeneral Lab Bosch Presents Pharmaceutical Laboratory Equipment Portfolio at CPhI Worldwide
Industry NewsSeparations In the News this Week: Highlights from AACC, Scientists’ Choice Awards & UHPLC Innovations
Product NewsSeparations In the News this Week: Blood Test for Cancer, EU Body-on-a-Chip Project & New Column Set Runs Seven EPA Methods
Product NewsGeneral Lab WHEATON® Highlights Products at AACC 2014 Offering Unique Solutions for the Clinical Market
Industry NewsDrug discovery > Target Discovery Major Scientific Achievement Enables Precision Drug Design for Inherited Learning Disabilities and Other Neurological Diseases
Product NewsLife Sciences In the News this Week: Innovative Drug Delivery Methods, New Dementia Research Campaign, and Scientists’ Choice Awards Voting Opens
Product NewsLife Sciences Biocartis and Abbott Announce Exclusive Partnership to Develop Multiplex Companion Diagnostics Tests
Product NewsSeparations Shimadzu and Indigo BioSystems Partner to Leverage the Power of ASCENT™ Clinical Solutions on Ultra-Fast Mass Spectrometry Platforms
Product NewsSeparations New Mass Spectral Library Designed to Streamline Environmental, Food Safety, Clinical Research and Forensic Toxicology Analyses
Product NewsGeneral Lab Revolutionary Nanoparticle Based Drug Delivery – Targeted Cancer Therapeutics Interview